Top interviews, articles, and news in the Monoclonal Antibodies industry, curated by AZoLifeSciences - The A to Z of Life Sciences.
The global research antibodies market size was valued at USD 1.41 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.93% from 2022 to 2030. B cells produce the proteins known as antibodies, which are a component of the immune system in the human body.
Just the monoclonal antibodies market size was valued at $146,642M in 2020 and is projected to duplicate by 2030. Monoclonal antibody (mAbs) therapy is a form of immunotherapy that targets specific proteins and cells in the body. The types of antibodies used in these therapies are murine, chimeric, humanized, and fully human. Current uses of this research include cancer treatments, Alzheimer’s, autoimmune diseases, and certain inflammatory conditions.
AZoLifeSciences have compiled a collection of the most popular mAbs articles, news, interviews, and industry insights over the last 12 months - Everything you need to know about the state of monoclonal antibodies therapy in one place.
Free eBook Contents
- Top interviews with thought leaders in the monoclonal antibodies sector, conducted by our editors.
- Top monoclonal antibody therapy news pieces written by our scientific collaborators.
- Top immunotherapy articles taking a deeper look into the industry discoveries and research.
- Sources, further reads, and related stories you can find on AZoLifeSciences.
Download your free eBook
Download the eBook